Cargando…
Prostate Cancer Drug Therapy: What Have Clinicians Missed During the COVID-19 Pandemic
Due to the COVID-19 pandemic, major congresses and many teaching opportunities as well as the usual visits from medical advisors of pharmaceutical firms have been postponed and canceled. The major trials of prostate cancer in the last 5 years in each state are shortly discussed providing a panoramic...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380218/ https://www.ncbi.nlm.nih.gov/pubmed/35950609 http://dx.doi.org/10.1177/15579883221115593 |